Literature DB >> 33864507

Frequency of bacteremia in patients with sickle cell disease: a longitudinal study.

Jaffar A Al-Tawfiq1,2,3, Ali A Rabaan4, Mohammed H AlEdreesi5.   

Abstract

Bacterial infections in sickle cell disease (SCD) are associated with major risks of morbidity and mortality. Here, we describe the occurrence of bacteremia in SCD patients from 2000 to 2017. This is an observational study which included children and adults with SCD and fever and had confirmed positive blood cultures. During the study period, there were 1095 SCD patients with 17,053 blood cultures. Of all the patients, 699 (63.8%) were children and 396 (36.2%) adults with 576 (52.6%) males and 519 (47.4%) females. The mean age ± SD was 17.8 (± 14.7), and a median age (IQR) of 13.6 (6.8-23.5) years. The mean (SD) follow up was 7.4 (5.4) years and the total number of patient-years was 8069.1 years. Out of the 1095 patients, 91 (8.3%) had bacteremia with 35 (38.5%) children and 65 (61.5%) adults (p = .079). The rate of bacteremia in all patients, children, and adults were 1.5 (95% CI: 1.3-1.8), 0.6 (95% CI: 0.4-0.8), and 2.4 (95% CI: 1.8-3.1) per 100 patient-years, respectively. The risk of Gram-positive bacteremia was 0.5 (96% CI: 0.36-0.69) in all patients, 0.1 (95% CI: 0.06-0.20) in children, and 1.4 (95% CI: 1.0-2.0) in adults per 100 patient-years. The risk of Gram-negative bacteremia was 1.0 (95% CI: 0.81-1.3) in all patients, 0.6 (95% CI: 0.4-0.8) in children, and 2 (95% CI: 1.5-2.7) in adults per 100 patient-years. The risk of Gram-negative bacteremia was higher than Gram-positive bacteremia in children (p < .001) but not in adults (p = .113) and adults had higher risk in general than children. In this study of SCD cohort, 8.3% had bacteremia with predominant Gram-negative infections. Bacteremia was more frequently encountered in the adult age group. Further studies are needed to verify the findings and explore possible reasons predisposing SCD patients to bacteremia.

Entities:  

Keywords:  Bacteremia; SCD; Sickle cell disease

Mesh:

Year:  2021        PMID: 33864507     DOI: 10.1007/s00277-021-04523-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  19 in total

1.  Two different forms of homozygous sickle cell disease occur in Saudi Arabia.

Authors:  M A Padmos; G T Roberts; K Sackey; A Kulozik; S Bail; J S Morris; B E Serjeant; G R Serjeant
Journal:  Br J Haematol       Date:  1991-09       Impact factor: 6.998

2.  The prevalence of sickle cell anemia in Saudi children and adolescents. A community-based survey.

Authors:  Mahmood D Al-Mendalawi
Journal:  Saudi Med J       Date:  2009-03       Impact factor: 1.484

3.  The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey.

Authors:  Mansour M Al-Qurashi; Mohammad I El-Mouzan; Abdullah S Al-Herbish; Abdullah A Al-Salloum; Ahmad A Al-Omar
Journal:  Saudi Med J       Date:  2008-10       Impact factor: 1.484

4.  Epidemiology of bloodstream infections in children with sickle cell disease.

Authors:  Angela M Ellison; Kaede V Ota; Karin L McGowan; Kim Smith-Whitley
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

5.  Predictors of bacteremia in febrile children with sickle cell disease.

Authors:  Daniel C West; Emily Andrada; Rahman Azari; Arun A Rangaswami; Nathan Kuppermann
Journal:  J Pediatr Hematol Oncol       Date:  2002-05       Impact factor: 1.289

6.  Premarital screening for thalassemia and sickle cell disease in Saudi Arabia.

Authors:  Nasser Abdulrahman Alhamdan; Yagob Yousaf Almazrou; Fahad Mohammad Alswaidi; Abdul Jamil Choudhry
Journal:  Genet Med       Date:  2007-06       Impact factor: 8.822

7.  Outcomes of febrile events in pediatric patients with sickle cell anemia.

Authors:  Krishnaveni Sirigaddi; Inmaculada Aban; Amelia Jantz; Brandi M Pernell; Lee M Hilliard; Smita Bhatia; Jeffrey D Lebensburger
Journal:  Pediatr Blood Cancer       Date:  2018-08-01       Impact factor: 3.167

8.  Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.

Authors:  Thomas V Adamkiewicz; Sharada Sarnaik; George R Buchanan; Rathi V Iyer; Scott T Miller; Charles H Pegelow; Zora R Rogers; Elliott Vichinsky; John Elliott; Richard R Facklam; Katherine L O'Brien; Benjamin Schwartz; Chris A Van Beneden; Michael J Cannon; James R Eckman; Harry Keyserling; Kevin Sullivan; Wing-Yen Wong; Winfred C Wang
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

9.  The presentation, frequency, and outcome of bacteremia among children with sickle cell disease and fever.

Authors:  T B West; D W West; K Ohene-Frempong
Journal:  Pediatr Emerg Care       Date:  1994-06       Impact factor: 1.454

10.  Bacteremia risk and outpatient management of febrile patients with sickle cell disease.

Authors:  Marc N Baskin; Xin Lyn Goh; Matthew M Heeney; Marvin B Harper
Journal:  Pediatrics       Date:  2013-05-13       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.